PTPRC and Bloom syndrome: We extracted CD45+ CD11b+ macrophages and further analyzed them, finding that the treatment with SGZ significantly decreased the percentage of CD86 cell subsets in the BLM mice (Figure 2G), which is consistent with the results of the CD86 IF staining.